AGA Medical has received European CE Mark approval for its Amplatzer Vascular Plug 4, AVP 4. It is indicated for arterial and venous embolizations in the peripheral vasculature, giving physicians a more efficient procedure.

With its low profile, the AVP 4 allows delivery through a standard 0.038 diagnostic catheter. The physician can now choose to use one AVP 4 instead of what often becomes multiple coil implants – without factoring in the need for a catheter exchange, said the company.

John Barr, president and chief executive officer, AGA Medical, said: “The AVP 4 is a major technological advancement in the Amplatzer Vascular Plug Family and receiving CE Mark approval validates this achievement.

“The AVP 4 complements our other vascular plugs, providing physicians with advanced tools to treat vascular conditions, which have the potential to reduce procedure times while offering improved flexibility and cost effectiveness.”

AGA Medical will begin marketing the AVP 4 in Europe immediately.